Molecular and Genetic Analysis of Lung Cancer

Description

Investigators use a genome-wide approach within a case-control design to identify SNPs that show evidence of association with lung cancer risk and survival.

Study Start Date

June, 01 1993

Estimated Completion Date

September 2022

Interventions

No interventions cited

Study ID

Massachusetts General Hospital -- 1999P-004935

Status

Recruiting

Trial ID

NCT03029325

Study Type

Observational

Trial Phase

N/A

Enrollment Quota

10000

Sponsor

Massachusetts General Hospital

Inclusion Criteria

  • healthy controls: participants without evidence of any cancer
  • cases: pathology proven primary lung cancer

Exclusion Criteria

  • younger than 18 years old

Gender

All

Ages

18 Years and older

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Study Locations and Contact Information (6)

Study Location Distance Name Phone Email
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Andrea Shafer MPH 617-726-9274 None
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Andrea Shafer MPH 617-726-9274 None
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Andrea Shafer MPH 617-726-9274 None
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Andrea Shafer MPH 617-726-9274 None
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Andrea Shafer MPH 617-726-9274 None
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Andrea Shafer MPH 617-726-9274 None

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.